CNS pipeline · person
Alan Fisher, BCom, FCA
Non-Executive Chair of the board of Neuphoria Therapeutics (formerly Bionomics), a board member since September 2016 and Chair effective July 2023; he also chairs the Audit and Risk Management Committee. Managing Director of Fisher Corporate Advisory since 1997, he advises companies on mergers, acquisitions and equity raisings, and serves on the board of ASX-listed Thorney Technologies. He previously was a Corporate Finance Partner at Coopers & Lybrand and holds a B.Com. in Accounting from the University of Melbourne.
- 1 company
Courtesy Neuphoria Therapeutics
Current roles
- Neuphoria Therapeutics, Inc.Non-Executive Chair of the Board · Board2016–present
Appears with
People sharing a company with Alan.
- David Wilson · Neuphoria Therapeutics, Inc.
- Jane Ryan · Neuphoria Therapeutics, Inc.
- Liz Doolin · Neuphoria Therapeutics, Inc.
- Peter Miles Davies · Neuphoria Therapeutics, Inc.
- Spyridon "Spyros" Papapetropoulos · Neuphoria Therapeutics, Inc.
- Tim Cunningham · Neuphoria Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.